Macrophage Blood brain barrier Single photon emission computed tomography CD4+CD25+ regulatory T cells (Treg) transform the HIV-1 infected macrophage from a neurotoxic to a neuroprotective phenotype. This was demonstrated previously in a murine model of HIV-1 encephalitis induced by intracranial injection of HIV-1/vesicular stomatitis virus-infected bone marrow macrophages. In this report, relationships between Treg ingress of end organ tissues, notably the brain, and neuroprotection were investigated. Treg from EGFP-transgenic donor mice were expanded, labeled with indium-111, and adoptively transferred. Treg distribution was assayed by single photon emission computed tomography and immunohistochemistry. Treg readily migrated across the blood brain barrier and were retained within virusinduced neuroinflammatory sites. In non-inflamed peripheral tissues (liver and spleen) Treg were depleted. These observations demonstrate that Treg migrate to sites of inflammation where they modulate immune responses.
Introduction
Despite the widespread use of antiretroviral therapies (ART), the incidence of milder forms of HIV-associated neurocognitive disorders (HAND) continues to rise (Letendre et al., 2007) . HAND is seen in up to 50% of infected people and characterized by a range of cognitive, motor and behavioral abnormalities ranging from asymptomatic neurocognitive disorder to frank dementia (Antinori et al., 2007) . In its most severe form, HIV-1 associated dementia (HAD) occurs often with an overt encephalitis with the formation of multinucleated giant cells, myelin pallor, astrogliosis, microglial nodules and neuronal drop-out. Disease is heralded through the trafficking of virus-infected monocyte-derived macrophages that migrate across the blood brain barrier (BBB) (Gartner, 2000) . Cells that ingress the brain are commonly viewed as the principal pathological indicator for disease severity (Gendelman et al., 1994) . Microglial inflammatory responses with cytokine and chemokine dysregulation are the benchmarks of disease (Buckner et al., 2006; Chadwick et al., 2008; Kolson and Pomerantz, 1996; Mollace et al., 2001; Roberts et al., 2003) .
Ways to modulate microglial inflammatory responses continue to be a major thrust towards adjuvant therapies in HAND. One possible means to achieve such microglial immunoregulation is through CD4 +CD25+ regulatory T cells (Treg). Natural Treg originate in the thymus, emigrate and exist in the periphery as a small fraction of circulating CD4+ T cells commonly identified by expression of high cell surface levels of IL-2Rα (CD25) and the transcription factor FoxP3 (Sakaguchi, 2004) . In the last two decades, Treg were shown to functionally modulate a variety of immune responses and maintain peripheral tolerance (Hara et al., 2001; Thornton and Shevach, 1998) . Importantly, Treg modulate anti-inflammatory activities in experimental models of HAND. In these models, Treg readily elicit neuroprotection associated with up-regulation of brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF) expression and potent down-regulation of pro-inflammatory cytokines, oxidative stress and control of viral replication (Liu et al., 2009) .
Treg are involved in modulating host cellular immunity in cancer (Curiel et al., 2004; Wang et al., 2004) , infectious diseases (Beilharz et al., 2004; Dittmer et al., 2004) , and autoimmune diseases (Boyer et al., 2004) , and are being developed for therapeutics for inflammatoryand autoimmune-mediated disorders (Bluestone, 2005; Mekala and Geiger, 2005; Tarbell et al., 2004; Trenado et al., 2003) . Indeed, expanded Treg maintain regulatory function and suppress proliferation and cytokine secretion of responder peripheral blood mononuclear cells in co-cultures stimulated with CD3-specific antibodies (Hoffmann et al., 2004; Ring et al., 2007; Tang and Bluestone, 2006) . In healthy individuals, lymphocyte traffic into the CNS is very low and tightly controlled by the highly specialized BBB. However, several Journal of Neuroimmunology 230 (2011) 33-41 
